Equity Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of information pertaining to option activity

Information pertaining to option activity during 2023 is as follows (number of options and aggregate intrinsic value in thousands):

	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value
Outstanding at December 25, 2022	235	$	56.53
Exercised	(43)	52.56
Cancelled	(1)	70.96
Outstanding at December 31, 2023	191	$	57.35	3.60	$	3,681
Exercisable at December 31, 2023	191	$	57.35	3.60	$	3,681

Summary of the significant assumptions used in estimating the fair value of performance based restricted stock units granted

The following is a summary of the significant assumptions used in estimating the fair value of the performance-based restricted stock units granted in 2023, 2022 and 2021:

Assumptions:	2023		2022		2021
Risk-free interest rate	4.5	%	1.5	%	0.2	%
Expected volatility	38.6	%	45.0	%	48.3	%

Schedule of information pertaining to restricted stock activity

Information pertaining to these awards during 2023 is as follows (shares in thousands):

	Shares	Weighted Average Grant-Date Fair Value
Total as of December 25, 2022	518	$	91.23
Granted	283	84.13
Forfeited	(92)	95.18
Vested	(226)	75.88
Total as of December 31, 2023	483	$	93.27